ENST00000379989.6:c.2927C>T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BS1BP4BP2

This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Pro976Leu variant in CDKL5 is 0.01% in South Asian sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Pro976Leu variant is observed in the CDKL5 gene where a second pathogenic variant in the same gene is present in the patient (internal database) (BP2). Computational analysis prediction tools suggest that the p.Pro976Leu variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Pro976Leu variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS1, BP2, BP4). LINK:https://erepo.genome.network/evrepo/ui/classification/CA171640/MONDO:0100039/016

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 0 hem., cov: 24)
Exomes 𝑓: 0.000039 ( 0 hom. 17 hem. )

Consequence

CDKL5
ENST00000379989.6 missense

Scores

2
15

Clinical Significance

Likely benign reviewed by expert panel B:6

Conservation

PhyloP100: -0.140

Publications

1 publications found
Variant links:
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
RS1 (HGNC:10457): (retinoschisin 1) This gene encodes an extracellular protein that plays a crucial role in the cellular organization of the retina. The encoded protein is assembled and secreted from photoreceptors and bipolar cells as a homo-oligomeric protein complex. Mutations in this gene are responsible for X-linked retinoschisis, a common, early-onset macular degeneration in males that results in a splitting of the inner layers of the retina and severe loss in vision. [provided by RefSeq, Oct 2008]
RS1 Gene-Disease associations (from GenCC):
  • retinoschisis
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • X-linked retinoschisis
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP2
For more information check the summary or visit ClinGen Evidence Repository.
BP4
For more information check the summary or visit ClinGen Evidence Repository.
BS1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RS1NM_000330.4 linkc.185-3207G>A intron_variant Intron 3 of 5 ENST00000379984.4 NP_000321.1 O15537
CDKL5NM_001037343.2 linkc.2927C>T p.Pro976Leu missense_variant Exon 21 of 22 NP_001032420.1 O76039-1
CDKL5NM_003159.3 linkc.2927C>T p.Pro976Leu missense_variant Exon 20 of 21 NP_003150.1 O76039-1
RS1XM_047442337.1 linkc.-156G>A 5_prime_UTR_variant Exon 1 of 4 XP_047298293.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RS1ENST00000379984.4 linkc.185-3207G>A intron_variant Intron 3 of 5 1 NM_000330.4 ENSP00000369320.3 O15537

Frequencies

GnomAD3 genomes
AF:
0.0000267
AC:
3
AN:
112533
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000563
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000436
AC:
8
AN:
183387
AF XY:
0.0000295
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000733
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000392
AC:
43
AN:
1098034
Hom.:
0
Cov.:
30
AF XY:
0.0000468
AC XY:
17
AN XY:
363392
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26398
American (AMR)
AF:
0.00
AC:
0
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.0000516
AC:
1
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30203
South Asian (SAS)
AF:
0.0000923
AC:
5
AN:
54147
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40508
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.0000416
AC:
35
AN:
841957
Other (OTH)
AF:
0.0000434
AC:
2
AN:
46092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000267
AC:
3
AN:
112533
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
34705
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30973
American (AMR)
AF:
0.00
AC:
0
AN:
10660
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2653
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3582
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2732
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6216
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.0000563
AC:
3
AN:
53276
Other (OTH)
AF:
0.00
AC:
0
AN:
1514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.558
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000391
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.0000412
AC:
5
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

Significance: Likely benign
Submissions summary: Benign:6
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:3
Oct 09, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 28, 2018
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 15, 2014
RettBASE
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:curation

In exon 20, only affects original isoforms; In silico prediction: SIFT = tolerated, MutationTaster = polymorphism, PolyPhen2 = benign, AlignGVGD = benign (C0) -

CDKL5 disorder Benign:2
Jul 22, 2024
Centre for Population Genomics, CPG
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:curation

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as likely benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is between 0.008% and 0.03% (BS1). Computational prediction analysis tools suggest no impact on gene product (REVEL score <= 0.15) (BP4). -

Mar 26, 2021
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel
Significance:Likely benign
Review Status:reviewed by expert panel
Collection Method:curation

The allele frequency of the p.Pro976Leu variant in CDKL5 is 0.01% in South Asian sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Pro976Leu variant is observed in the CDKL5 gene where a second pathogenic variant in the same gene is present in the patient (internal database) (BP2). Computational analysis prediction tools suggest that the p.Pro976Leu variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Pro976Leu variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS1, BP2, BP4). -

Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Oct 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.84
DANN
Benign
0.96
DEOGEN2
Benign
0.031
T;T
FATHMM_MKL
Benign
0.012
N
LIST_S2
Benign
0.47
.;T
M_CAP
Pathogenic
0.38
D
MetaRNN
Benign
0.052
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;N
PhyloP100
-0.14
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.49
N;N
REVEL
Benign
0.11
Sift
Benign
0.38
T;T
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.0
B;B
Vest4
0.030
MutPred
0.41
Gain of sheet (P = 0.0016);Gain of sheet (P = 0.0016);
MVP
0.14
MPC
0.88
ClinPred
0.062
T
GERP RS
-2.2
Varity_R
0.028
gMVP
0.31
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587783161; hg19: chrX-18668659; COSMIC: COSV101183804; COSMIC: COSV101183804; API